U.S. Patient Engagement Solutions Market Share Analysis Report, 2023-2032
The U.S. patient engagement solutions market size was exhibited at USD 6.58 billion in 2022 and is projected to hit around USD 46.50 billion by 2032, growing at a CAGR of 21.6% during the forecast period 2023 to 2032.
Key Pointers:
U.S. Patient Engagement Solutions Market Report Scope
|
Report Coverage |
Details |
|
Market Size in 2023 |
USD 8.00 Billion |
|
Market Size by 2032 |
USD 46.50 Billion |
|
Growth Rate from 2023 to 2032 |
CAGR of 21.6% |
|
Base year |
2022 |
|
Forecast period |
2023 to 2032 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Delivery type, component, functionality, therapeutic area, application, end-user |
|
Key companies profiled |
Cerner Corporation (Oracle); NextGen Healthcare, Inc.; Epic Systems Corporation; Allscripts Healthcare, LLC; McKesson Corporation; ResMed; Koninklijke Philips N.V.; Klara Technologies, Inc.; CPSI; Experian Information Solutions, Inc.; athenahealth, Inc. |
The key factors driving the market growth include rising digitalization in healthcare, the prevalence of chronic conditions, adoption by patients, and the COVID-19 pandemic.
The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Certain trends, which grew steadily in the past decades, including digital healthcare solutions, unexpectedly became omnipresent as lockdowns directed remote operations and large-scale reliance on technology. In addition, the COVID-19 pandemic has shown the importance for clinicians to have rapid and full access to a patient's history to make the best-informed decision about their care. This propelled the growth of the market.
For instance, in February 2020, Solutionreach, Inc. launched SR Health, an AI-based patient engagement platform for hospitals, health systems, and enterprise healthcare organizations. This was followed by the addition of vaccine distribution messaging as part of its SR Health COVID-19 Communications solution, in January 2021. A large population over the age of 60 is a key driver for the U.S. patient engagement solutions market. This is owing to lower immunity levels in the geriatric population and higher vulnerability to chronic conditions such as obesity, cardiac problems, and cancer.
In fact, as per the U.S. Census Bureau, the median age of the country’s population is estimated to reach age 43 by 2060 with just two-and-a-half working-age adults for every retirement-age individual. This indicates an aging U.S. population that is more likely to avail the best possible treatments to increase life span. The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies. The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies.
Chronic ailments are the leading cause of disability & death and are the leading drivers of the country’s USD 3.8 trillion 12-monthly healthcare costs, according to the CDC. The COVID-19 outbreak has expedited the necessity for digital solutions, highlighting the need for remote care, which is not only preferred but also essential. Increasing adoption of mobile platforms coupled with the dissemination of uninterrupted 3G, 4G networks, and emerging 5G technology, are rapidly boosting the use of mobile health.
Furthermore, there has been an incredible upsurge in the use of mobile phones and the internet by physicians in the U.S. leading to the progress of mobile health solutions. The usage of mobile applications has proven to be very effective in spreading awareness about chronic diseases, managing personal health, communicating with healthcare providers, and maintaining health records. This is expected to fuel the market growth.
Delivery Type Insights
The web & cloud-based solutions segment dominated the U.S. patient engagement solutions market by delivery type in 2022 and is also anticipated to expand at the fastest CAGR of over 15%. Government initiatives such as the Electronic Health Record Incentive Program, which aims at increasing U.S. patient engagement with the help of patient portals, are anticipated to propel the growth during the forecast period.
In May 2019, Icon plc released a web-based clinical trial platform, to deliver patients with study-related data and connectivity with the nearest investigative location. Elsevier, on the other hand, launched PatientPass, a cloud-based patient education platform in the U.S. in September 2020. In October 2020, Cerner extended its partnership with Amazon Web Services (AWS) by allowing users of the Halo fitness tracker to share data directly with their providers. The collaboration with Amazon also includes the migration of many of Cerner’s solutions to the public cloud.
Component Insights
The software & hardware segment contributed to the largest share of the market by component, as patient engagement solutions are primarily software-centric. Patient engagement solutions help doctors educate the patients and engage them in order to enhance treatment efficiency. It helps in recording patient information and helping the doctors in setting patient appointments, diet, and medication records. The patient-doctor sessions can be recorded and stored on patient portals for further analysis and interpretations. This facilitates patient participation and reduces the readmission rate.
The growing use of mhealth Apps and remote monitoring devices is also expected to contribute to segment growth. In addition, the services segment is also estimated to grow notably during the forecast period. As more and more healthcare organizations, clinics, and hospitals adopt digital health solutions, it is expected to increase demand for training, consulting, implementation, and support & maintenance services, thus driving the segment growth.
Functionality Insights
The communication segment held over 36.9% of the market in 2022, while the health tracking & insights segment is anticipated to progress at the fastest rate of over 16% in the coming years. In August 2020, Loudoun Medical Group in the U.S. utilized IBM’s Phytel to automate outreach to its diabetic patient population. This resulted in USD 192,000 in revenue and helped the Loudoun Medical Group to enhance the quality of care provided to its patients. Communication technologies form the core of patient engagement solutions.
The COVID-19 pandemic further propelled the development, integration, and adoption of communication solutions such as telehealth, remote data exchange, remote monitoring, and online payments. The application of AI, analytics, and machine learning in patient engagement is expected to enhance tracking and reporting capabilities. This, in turn, is anticipated to increase patient compliance in tracking their health journey and improve patient outcomes in the long term.
Application Insights
Outpatient health management held over 39% of the market in terms of application. The others segment, comprising patient engagement for clinical studies and preventive care, is projected to expand at the fastest rate of more than 15% during the forecast period. This is due to market players developing newer products to help simplify the management of health at individual and large population levels.
dbMotion, for example, is an interoperable platform for population health management, offered by Allscripts Healthcare. Amadeus by Orion health is another population health management solution that serves as a foundation platform for the company’s care management and patient engagement applications. Aerial platform by Medecision is a scalable, SaaS solution used by home health and community-based organizations among others, to provide personalized member and patient engagement.
Therapeutic Area Insights
Chronic disease management represented the largest share of over 45% of the U.S. patient engagement solutions industry in 2022. According to the National Center for Chronic Disease Prevention and Health Promotion estimates, 4 in 10 Americans suffer from 2 or more chronic diseases. Rising tobacco use, poor nutrition, lack of physical activity, and alcoholism were identified as the key contributors to the rising incidence of chronic diseases in the U.S.
Health & wellness segment, on the other hand, is expected to register exponential growth of more than 15.4% during the forecast period. This is owing to the increasing adoption of patient engagement solutions in preventive care and general health management, such as weight management and mental health. Concerns and awareness regarding mental health, for instance, are driving patients and providers to adopt novel ways to track treatment.
Patient engagement solutions allow providers and patients to stay connected during the patient's care journey and ensure optimum delivery of care. As per the National Institute of Mental Health, 51.5 million American adults lived with a mental illness in 2019. The growing number of patients seeking treatment for mental health disorders ranging from depression to panic disorders is expected to propel the market growth.
End User Insights
Providers contributed over 47.19% of the market share by end-user in 2022. The payers segment, on the other hand, is expected to register the highest growth of over 15% in the coming years. This is owing to the rising need to deliver care and patient education in an engaging way for chronic disease management. Medhost’s YourCare Everywhere is a health and wellness consumer engagement solution designed to enable two-way communication between patients and providers.
Force Therapeutics Platform, on the other hand, provides video-based education, messaging, digitized workflows, data & analytics, and other features to achieve better patient outcomes. The increasing use of mobile health and advancements in cloud technology is expected to boost the adoption of patient engagement solutions in the near future. Payers are adopting risk-sharing strategies with providers, with an intention to manage consumer care and engage patients at every stage to manage chronic health conditions.
Some of the prominent players in the U.S. Patient Engagement Solutions Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Patient Engagement Solutions market.
By Delivery Type
By Component
By Functionality
By Therapeutic Area
By Application
By End User
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates & Forecast Timeline
1.1.3 Research Scope and Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 U.S. Patient Engagement Solutions Market Outlook, 2020-2032
2.2 U.S. Patient Engagement Solutions Market Summary, 2023
Chapter 3 Market Variables, Trends & Scope
3.1 U.S. Patient Engagement Solutions Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Rising Geriatric Population
3.1.3 Increasing Prevalence of Chronic Conditions
3.1.3.1 Neurological disorders
3.1.3.2 Cancer
3.1.3.3 Type 2 diabetes
3.1.4 Favorable Government Initiatives
3.1.5 Increasing Use of Mobile Health
3.1.6 Increasing Investments by Stakeholders
3.1.7 Market Restraint Analysis
3.1.8 Protection of Patient Information
3.1.9 Requirement for Infrastructure
3.2 Penetration & Growth Prospect Mapping
3.3 U.S. Patient Engagement Solutions Market Analysis Tools: Porter’s Five Forces Analysis
3.4 U.S. Patient Engagement Solutions: SWOT Analysis by Factors (Political & Legal, Economic, Social and Technological)
3.5 Target Audience
3.5.1 List of Key Buyers
3.6 Buyer’s Preference Analysis
3.7 Potential Target Audience
3.8 Changing Technology & Their Adoption
3.8.1 Adoption Rate of Changing Technology
3.8.2 Timeline with Major Technology Changes
3.9 Product & Service Analysis
Chapter 4 U.S. Patient Engagement Solutions Market: Covid-19 Impact
4.1 Impact of COVID-19 on the U.S. Patient Engagement Solutions Application Market
4.2 Regulatory/Policy Changes
4.3 Opportunity Analysis
4.3.1 Increasing Government Initiatives
4.4 Strategies Adopted by Market Players
Chapter 5 U.S. Patient Engagement Solutions Market: Delivery Type Estimates & Trend Analysis
5.1 Delivery Type Market Share Analysis, 2023 & 2032
5.2 Delivery Type Dashboard
5.3 Web-based
5.3.1 Web-based market estimates and forecasts, 2020 - 2032
5.4 Cloud-based
5.4.1 Cloud-based market estimates and forecasts, 2020 - 2032
5.5 On-premise
5.5.1 On-premise market estimates and forecasts, 2020 - 2032
Chapter 6 U.S. Patient Engagement Solutions Market: Component Estimates & Trend Analysis
6.1 Component Market Share Analysis, 2023 & 2032
6.2 Component Dashboard
6.3 Software
6.3.1 Software market estimates and forecasts, 2020 - 2032
6.3.2 Standalone Software
6.3.2.1 Standalone software market estimates and forecasts, 2020 - 2032
6.3.3 Integrated Software
6.3.3.1 Integrated software market estimates and forecasts, 2020 - 2032
6.4 Hardware
6.4.1 Hardware market estimates and forecasts, 2020 - 2032
6.5 Services
6.5.1 Services market estimates and forecasts, 2020 - 2032
6.5.2 Consulting
6.5.2.1 Consulting services market estimates and forecasts, 2020 - 2032
6.5.3 Implementation
6.5.3.1 Implementation services market estimates and forecasts, 2020 - 2032
6.5.4 Education
6.5.4.1 Educational services market estimates and forecasts, 2020 - 2032
6.5.5 Other Services
6.5.5.1 Other services market estimates and forecasts, 2020 - 2032
Chapter 7 U.S. Patient Engagement Solutions Market: Application Estimates & Trend Analysis
7.1 Application Market Share Analysis, 2023 & 2032
7.2 Application Dashboard
7.3 Social Management
7.3.1 Social management market estimates and forecasts, 2020 - 2032
7.4 Health Management
7.4.1 Health management market estimates and forecasts, 2020 - 2032
7.5 Home Healthcare Management
7.5.1 Home healthcare market estimates and forecasts, 2020 - 2032
7.6 Financial Health Management
7.6.1 Financial health management market estimates and forecasts, 2020 - 2032
Chapter 8 U.S. Patient Engagement Solutions Market: End-use Estimates & Trend Analysis
8.1 End-Use Market Share Analysis, 2023 & 2032
8.2 End-use Dashboard
8.3 Providers
8.3.1 Providers market estimates and forecasts, 2020 - 2032
8.4 Payers
8.4.1 Payers market estimates and forecasts, 2020 - 2032
8.5 Individual Users
8.5.1 Individual users market estimates and forecasts, 2020 - 2032
Chapter 9 U.S. Patient Engagement Solutions Market: Therapeutic Area Estimates & Trend Analysis
9.1 Therapeutic Area Market Share Analysis, 2023 & 2032
9.2 Therapeutic Area Dashboard
9.3 Chronic Diseases
9.3.1 Chronic diseases market estimates and forecasts, 2020 - 2032
9.3.2 Diabetes
9.3.2.1 Diabetes market estimates and forecasts, 2020 - 2032
9.3.3 Cardiovascular Diseases
9.3.3.1 Cardiovascular diseases market estimates and forecasts, 2020 - 2032
9.3.4 Obesity
9.3.4.1 Obesity market estimates and forecasts, 2020 - 2032
9.4 Women’s Health
9.4.1 Women’s health market estimates and forecasts, 2020 - 2032
9.5 Mental Health
9.5.1 Mental health market estimates and forecasts, 2020 - 2032
9.6 Fitness
9.6.1 Fitness market estimates and forecasts, 2020 - 2032
9.7 Other Therapeutic Areas
9.7.1 Other therapeutic areas market estimates and forecasts, 2020 - 2032
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Company Profiles
10.2.1 Allscripts Healthcare, LLC
10.2.1.1 Company Overview
10.2.1.2 Financial Performance
10.2.1.3 Product Benchmarking
10.2.1.4 Strategic Initiatives
10.2.2 Orion Health
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Cerner Corporation
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 McKesson Corporation
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 athenahealth, Inc.
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 IBM
10.2.6.1 COMPANY Overview
10.2.6.2 Financial Performance
10.2.6.3 Product Benchmarking
10.2.6.4 Strategic Initiatives
10.2.7 Medecision
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 GetWellNetwork, Inc.
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 MEDHOST
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
10.2.10 Lincor
10.2.10.1 Company Overview
10.2.10.2 Financial Performance
10.2.10.3 Product Benchmarking
10.2.10.4 Strategic Initiatives
10.2.11 IQVIA
10.2.11.1 Company Overview
10.2.11.2 Financial Performance
10.2.11.3 Product Benchmarking
10.2.11.4 Strategic Initiatives
10.2.12 Wolters Kluwer N.V.
10.2.12.1 Company Overview
10.2.12.2 Financial Performance
10.2.12.3 Product Benchmarking
10.2.12.4 Strategic Initiatives
10.2.13 Force Therapeutics LLC
10.2.13.1 Company Overview
10.2.13.2 Financial Performance
10.2.13.3 Product Benchmarking
10.2.13.4 Strategic Initiatives
10.2.14 Quil
10.2.14.1 Company Overview
10.2.14.2 Product Benchmarking
10.2.14.3 Strategic Initiatives
10.2.15 Greenway Health, LLC
10.2.15.1 Company Overview
10.2.15.2 Financial Performance
10.2.15.3 Product Benchmarking
10.2.15.4 Strategic Initiatives
10.2.16 Mytonomy
10.2.16.1 Company Overview
10.2.16.2 Financial Performance
10.2.16.3 Product Benchmarking
10.2.16.4 Strategic Initiatives
10.2.17 Klara Technologies, Inc.
10.2.17.1 Company Overview
10.2.17.2 Financial Performance
10.2.17.3 Product Benchmarking
10.2.17.4 Strategic Initiatives
10.2.18 Solutionreach, Inc.
10.2.18.1 Company Overview
10.2.18.2 Financial Performance
10.2.18.3 Product Benchmarking
10.2.18.4 Strategic Initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers